And reading this article we’re reminded again of a recent post where a doctor characterized medical cannabis as the “Swiss Army knife of medicines,” i.e., applicable across a wide range of diverse imbalances in the body’s endocannabinoid system (ECS)… …with a number of possible applications mentioned here which we haven’t covered before….
These are for sure exciting times in medicinal cannabis world, with the naysayers looking more blindered and further on the wrong side of history every day…
Excerpts (much more in the article):
“Hebrew University Prof. Raphael Mechoulam, known as the ‘father’ of the medical cannabis industry, will lead a team investigating the benefits of non-psychoactive cannabis components for treating asthma and other respiratory conditions.
In 1964 [53 years ago and still going strong as a researcher!], Mechoulam, was the first scientist to successfully isolate the THC component in cannabis.
…Allergic diseases including asthma, allergic rhinitis, atopic dermatitis and food allergies affect approximately 20 percent of the global population.
Mechoulam’s asthma research aim is to identify “a possible inhibitory effect of a derivative of cannabidiol (CBD) on allergic airway inflammation.”
While asthma and allergies are generally well controlled by steroids or symptomatic drugs, some patients are steroid-resistant and have thus been labeled as ‘unmet clinical needs’ by the World Health Organization.
Of the 140 cannabinoid molecules in the cannabis plant, the two main components are THC (the psychoactive component) and CBD, which has anti-inflammatory properties. CBD is the focus of much of Israel’s burgeoning medical cannabis research on diabetes, heart disease, autism, fracture healing and inflammatory bowel disease.”
#MMJ #Research #Asthma #Israel #CBD #UTpol #UtahNext #TRUCE
http://ift.tt/2AmkhY8
See full article – Compound in cannabis could ease asthma
